ALSUntangled does not recommend the Deanna Protocol for amyotrophic lateral sclerosis
Original source
Deanna Protocol (opens in a new tab)ALSUntangled does not recommend the Deanna Protocol because there is no convincing objective evidence that it benefits people with amyotrophic lateral sclerosis (ALS). Anecdotal reports exist, but the protocol has not been shown to improve meaningful measures such as ALSFRS-R or forced vital capacity (FVC).
Why this matters
People with ALS and their clinicians should not consider the protocol an evidence-supported treatment based on the available review. More research would need to show reproducible biological effects and meaningful clinical benefits before it could be recommended.
Limitations and context
This is an independent expert review published in 2013, not a new clinical trial or primary research study. It notes anecdotal reports but does not provide convincing objective evidence of benefit. The review says further work is needed to assess both biological mechanisms and clinical outcomes.